case study Comprehensive Oligonucleotide Development Program Executive Summary Catalent has successfully completed several antisense oligonucleotides projects in various phases of clinical studies for three pharmaceutical companies. These projects required method development, phase appropriate validation and long-term stability studies of their drug substances and drug products, and testing of the in-process samples. Catalent has extensive

Join for free to read